FinBoss.io
CSEN
  • Home
  • Crypto prices
  • Bitcoin on-chain
  • US macro
  • US stocks
  • Guides
  • How we make money
FinBoss.io
Home
Crypto prices
Bitcoin on-chain
Hashrate
Mining difficulty
Mining pools
Mempool and fees
On-chain activity
MVRV and NUPL
SOPR
Holders
Supply in profit
Rainbow Chart
Fair value
Pi Cycle Top
US macro
FedWatch
Interest rates
Treasury yields
Inflation
Liquidity and Bitcoin
Business cycle
US stocks
Stock screener
Earnings calendar
Insider trading
Market heatmap
Guides
How we make money
CSEN
Home
Stocks
GE Healthcare Technologies Inc.
GE

GE Healthcare Technologies Inc.

GEHCHealth care

Stock · Data from SEC EDGAR 13F · Held by 14 of 87 tracked investors

$71.45
▲ 0.10%
Famous investorshold 14buying 0selling 0
Price (USD)
$71.45
Market cap
$32.3B
P/E ratio
16.4
Tracked investors holding
14 of 87
Next earnings
28 Oct 2026

GE Healthcare Technologies Inc. at a glance

An overview of the financial statements, in plain language. Switch to the advanced view for charts.

FinBoss score
67out of 100
  • Valuation81
  • Growth52
  • Profitability64
  • Quality68
  • Debt50
  • Stability90
In its favour

Earnings results

QuarterReportedEPSAnalyst estimateSurprise
Jun 202629 Jul 20261.131.04+8.7%
Mar 202629 Apr 20260.991.07-7.5%
Dec 20254 Feb 20261.441.43+0.7%
Sep 202529 Oct 20251.071.05+1.9%

EPS is earnings per share. The surprise is the difference against the analysts' consensus. Source: Nasdaq, in dollars.

7D
+2.70%
1M
+7.64%
3M
+17.94%
YTD
-13.73%
1Y
-8.56%
3Y
+13.23%
5Y
—
Forward P/E
13.2
Dividend yield
0.22%
52-week low
$58.75
52-week high
$89.77

Chart GEHC

Insider purchases

last 90 days, SEC Form 4
Loading insider trades…

Which investors hold this stock

14
NP
Nelson Peltz
Trian Fund Management
4.67%$197,492,869▲ +76,194.4%
LC
Leon Cooperman
Cooperman (Omega Family Office)
2.36%$83,821,095▲ +95.4%
BN
Bill Nygren
Oakmark (Harris Associates)
1.3%$981,251,810▼ -1.7%
JG
Joel Greenblatt
Gotham Asset Management
0.09%$37,407,124▲ +77.7%
SC
Steven Cohen
Point72 Asset Management
0.08%$74,633,932▲ +832.3%
Ns
Norský státní fond
Norges Bank
0.04%$372,763,771New position
Šn
Švýcarská národní banka
Swiss National Bank
0.04%$82,373,637▼ -3.7%
Čn
Česká národní banka
Česká národní banka
0.04%$8,483,719unchanged
CB
Christopher Bloomstran
Semper Augustus Investments
0.03%$293,230unchanged
KG
Ken Griffin
Citadel Advisors
0.02%$151,513,718▲ +83%
CA
Cliff Asness
AQR Capital Management
0.02%$44,333,571▲ +379.1%
RD
Ray Dalio
Bridgewater Associates
0%$998,236▼ -78.3%
MG
Mario Gabelli
GAMCO Investors
0%$249,959▼ -7.7%
KF
Ken Fisher
Fisher Investments
0%$234,242▲ +13.8%

Frequently asked questions

How much is GE Healthcare Technologies Inc. (GEHC) stock?

GE Healthcare Technologies Inc. shares trade at $71.45, +0.10% over the last trading day. The price is delayed.

What is the market cap of GE Healthcare Technologies Inc.?

The market cap of GE Healthcare Technologies Inc. is about $32.3B and its price-to-earnings ratio (P/E) is 16.4.

Does GE Healthcare Technologies Inc. pay a dividend?

The dividend yield of GE Healthcare Technologies Inc. is 0.22% a year. The yield can change with the company's decisions.

How has GE Healthcare Technologies Inc. stock performed over the last year?

The GE Healthcare Technologies Inc. share price changed by -8.56% over 12 months.

Which big investors hold GE Healthcare Technologies Inc.?

According to the latest 13F filings, 14 of 87 tracked investors hold GE Healthcare Technologies Inc., for example Nelson Peltz, Leon Cooperman, Bill Nygren.

When will GE Healthcare Technologies Inc. report its next results?

The next earnings report of GE Healthcare Technologies Inc. is expected on 28 Oct 2026.

Source: SEC EDGAR 13F-HR (quarterly filings). The data is indicative and is not investment advice.

© 2026 FinBoss.io. All rights reserved.

How we make moneyTerms (Czech)Privacy (Czech)Cookies (Czech)

Disclaimer: the information on this site is for general information only and is not investment or financial advice. Investing involves risk, and cryptocurrencies are especially volatile. Past performance does not guarantee future results. Some links are affiliate links and are marked as ads.

  • ✓It earns 19 USD a year on every 100 USD of invested capital (ROE).
  • ✓It pays a 0.2% dividend, which takes 3% of earnings.
  • ✓The analysts' average target is 16% above the price.
  • What to watch
    • !Net debt is high: at the current free cash flow it would take 5.4 years to repay.

    The score describes the quality and the past of the company based on its statements (the FinBoss model, indicative). A high score is not a buy signal and a low one is not a sell signal. Data source: Yahoo Finance, prices and statements in USD.

    Is the stock expensive?

    Fairly cheap

    For 1 USD of annual earnings you pay 16.4 USD. Based on next year's estimates 13.2 USD.

    P/E
    16.4×
    P/S
    1.5×
    EV/EBITDA
    11.4×

    Is the company growing?

    Growing slowly
    22
    23
    24
    25

    Revenue over 3 years grew 4.0% a year. Last year 5.8%.

    Does it make money?

    Good
    • Cost of sales 60
    • Research 6.1
    • Operations and selling 20.5
    • Taxes and other 3.3
    • Net profit 10.1

    Out of 100 USD of revenue, 10.1 USD is left as net profit.

    Is it financially healthy?

    Mostly
    Cash
    2.1B USD
    Debt
    10.5B USD
    Free CF
    1.6B USD

    It could repay its net debt from free cash flow in 5.4 years.

    Does it pay a dividend?

    Pays
    Yield
    0.22%
    Of earnings
    3%

    Over a year you receive roughly 0.22% of the price per share. The payout is manageable for the company. It has raised the dividend for 2 years in a row.

    What do analysts expect?

    Buy
    Average target
    82.70 USD
    Vs price
    +16%

    20 analysts. Their opinion is not a recommendation by FinBoss.io.

    Which big investors hold it?

    14 of 87

    Among the tracked investors, Nelson Peltz, Leon Cooperman, Bill Nygren and others hold the stock according to 13F filings.

    Revenue and net profit (USD B)

    Margins (% of revenue)

    Free cash flow and capex (USD B)

    Cash and debt (USD B)

    Earnings per share (EPS, USD)

    Latest quarters (USD B)

    Dividend per share by year (USD)

    * the year has not ended yet. Source: Yahoo Finance.

    Ratios

    P/E
    16.4×
    Forward P/E
    13.2×
    P/B
    2.9×
    P/S
    1.5×
    PEG
    1.78
    EV/EBITDA
    11.4×
    Gross margin
    39.5%
    Operating margin
    15.0%
    Net margin
    9.3%
    ROE
    19.4%
    ROA
    5.1%
    Debt / equity
    0.9×
    Current ratio
    1.3×
    Revenue growth
    5.8%
    Earnings growth
    16.8%
    Beta
    0.85
    Dividend
    0.22%
    Payout ratio
    3%